Style | Citing Format |
---|---|
MLA | F Moeinzadeh FIROUZEH, et al.. "Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients." Journal of Research in Medical Sciences, vol. 30, no. 1, 2025, pp. -. |
APA | F Moeinzadeh FIROUZEH, S Shahidi SHAHRAZAD, R Heidari RAHELEH, M Mortazavi MOJGAN, M Mansourian MARJAN, Bb Yadegar Bahareh BOTLANI (2025). Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients. Journal of Research in Medical Sciences, 30(1), -. |
Chicago | F Moeinzadeh FIROUZEH, S Shahidi SHAHRAZAD, R Heidari RAHELEH, M Mortazavi MOJGAN, M Mansourian MARJAN, Bb Yadegar Bahareh BOTLANI. "Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients." Journal of Research in Medical Sciences 30, no. 1 (2025): -. |
Harvard | F Moeinzadeh FIROUZEH et al. (2025) 'Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients', Journal of Research in Medical Sciences, 30(1), pp. -. |
Vancouver | F Moeinzadeh FIROUZEH, S Shahidi SHAHRAZAD, R Heidari RAHELEH, M Mortazavi MOJGAN, M Mansourian MARJAN, Bb Yadegar Bahareh BOTLANI. Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients. Journal of Research in Medical Sciences. 2025;30(1):-. |
BibTex | @article{ author = {F Moeinzadeh FIROUZEH and S Shahidi SHAHRAZAD and R Heidari RAHELEH and M Mortazavi MOJGAN and M Mansourian MARJAN and Bb Yadegar Bahareh BOTLANI}, title = {Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients}, journal = {Journal of Research in Medical Sciences}, volume = {30}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - F Moeinzadeh FIROUZEH AU - S Shahidi SHAHRAZAD AU - R Heidari RAHELEH AU - M Mortazavi MOJGAN AU - M Mansourian MARJAN AU - Bb Yadegar Bahareh BOTLANI TI - Comparison of Survival Outcomes in Preemptive Versus Non-Preemptive Kidney Transplant Recipients JO - Journal of Research in Medical Sciences VL - 30 IS - 1 SP - EP - PY - 2025 ER - |